Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India EP News Bureau Aug 19, 2020 Dr Reddy’s AVIGAN comes in a pack of 122 tablets with a two-year shelf life
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India EP News Bureau May 26, 2020 Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India
Brinton Pharmato launch Favipiravir, a promising drug for COVID-19 EP News Bureau May 18, 2020 Favipiravir will be marketed by Brinton Pharmaceuticals under the brand name Faviton and will be available in 200mg and 400mg…
CSIR identifies top 25 drugs/drug candidates for repurposing Press Information Bureau May 1, 2020 Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs
DCGI approves Glenmark’s clinical trials of Favipiravir Antiviral tablets for COVID-19… EP News Bureau Apr 30, 2020 The product is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation